Drug-related ocular TEAEs
ocular TEAEs
Drug-related ocular TEAEs were reported for 20.8% of patients in the CsA CE high-dose group, 17.2% of those in the low-dose group, and 14.3% of those in the vehicle group. No serious ocular AEs were reported as related to study treatment. Discontinuation due to drug-related ocular TEAEs occurred in 3.1% of patients in the CsA CE high-dose group, no patients in the low-dose group, and 3.1% in the vehicle group. Individual drug-related ocular TEAEs are summarised in Table 